HEKA, the Inventor of AI Mattress, Launches the Sixth-Generation AI Mattress, Ushering in a New Era of Healthy Sleep
September 08, 2024 21:13 ET | iFutureLab Inc.
Recently, in Silicon Valley, the forefront of technological innovation, HEKA once again led the trend by globally launching its new generation AI mattress
MethanexLogo.jpg
Methanex Corporation Signs Definitive Agreement to Acquire OCI Global’s International Methanol Business for $2.05 Billion
September 08, 2024 21:00 ET | Methanex Corporation
Except where otherwise noted, all currency amounts are stated in United States dollars. Unique opportunity to acquire world-scale producing methanol assets with access to robust North American...
HUTCHMED-small-spaced-1000x305-WhiteBgd.png
HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2024 and the 2024 World Conference of Lung Cancer
September 08, 2024 20:00 ET | HUTCHMED (China) Limited
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, LEADING INVESTOR COUNSEL, Encourages Lifecore Biomedical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LFCR
September 08, 2024 19:22 ET | The Rosen Law Firm PA
NEW YORK, Sept. 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lifecore Biomedical, Inc. (NASDAQ: LFCR) between October 7,...
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
September 08, 2024 19:10 ET | MacroGenics, Inc.
ROCKVILLE, MD, Sept. 08, 2024 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative...
NVX New Logo.PNG
NOVONIX Announces Participation in the H.C. Wainwright Conference
September 08, 2024 18:55 ET | Novonix Ltd.
BRISBANE, Australia, Sept. 09, 2024 (GLOBE NEWSWIRE) -- NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX”), a leading battery materials and technology company, today announced that the company is...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, LEADING INVESTOR COUNSEL, Encourages Five Below, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FIVE
September 08, 2024 18:19 ET | The Rosen Law Firm PA
NEW YORK, Sept. 08, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Five Below, Inc. (NASDAQ: FIVE) between March 20, 2024...
upscaled logo.png
Ultimovacs Announces Updated Data Analysis on UV1 Phase II NIPU Trial in Mesothelioma at ESMO 2024
September 08, 2024 18:10 ET | Ultimovacs ASA
Oslo, September 9, 2024: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces the presentation of updated data...
avacta.png
Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
September 08, 2024 18:05 ET | Avacta Group
        8 September 2024 Avacta Group plc (“Avacta” or “the Group” or “the Company”) Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress ...
C4Therapeutics-Website-Logo-FullColor-(R).png
C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024
September 08, 2024 18:05 ET | C4 Therapeutics, Inc.
Abstract Released Today Highlights Favorable Safety Profile and Early Evidence of Monotherapy Anti-Tumor Activity Investor Webcast to be Held Friday, September 13, 2024 at 12:00 pm ET ...